News

JD Supra20h
Before it hits the shelf: FDA reprocesses the new dietary ingredient notification process
On June 11, 2025, the US Food and Drug Administration (FDA) released educational materials to broaden dietary supplement manufacturers’ ...
Millions of Americans Need These Drugs. RFK Jr.’s Minions Have Them in Their Crosshairs.
The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
FoodNavigator-USA2d
FDA’s 2025 Food Agenda: What industry must know
Explore the FDA’s 2025 Human Foods Program Guidance Agenda and what it means for US food and beverage businesses. Key ...
Dow Jones Top Company Headlines at 3 PM ET: FDA Authorizes Juul's E-Cigarettes After Ban Nearly Bankrupted Firm | Coinbase ...
GE Aerospace raised its full-year earnings outlook and beat expectations on its top and bottom lines in the second quarter. PepsiCo said its business remained resilient during the second quarter, ...
Stocktwits on MSN10d
Adagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns Optimistic
Adagene Inc. (ADAG) on Tuesday said that it received directions from the U.S. Food and Drug Administration on further ...
Health Affairs15d
Drug Coverage Policies And Clinical Guidelines Alignment: Most Coverage ...
Using the Tufts Medicine Specialty Drug Evidence and Coverage Database (December 2023), we reviewed US-based guidelines for 389 drug-indication pairs, excluding oncology and biosimilar treatments.
The National Law Review17d
FDA Guidance to Continue Despite 10-1 Deregulation Order
FDA Official Says FDA Plans to Issue Guidance as Normal Despite “10-1 Executive Order” Senior FDA officials recently signaled that the agency does not anticipate major disruptions to the ...
Targeted Oncology17d
FDA Draft Guidance Illuminates MDS Drug Development Pathways
The FDA's draft guidance specifically addresses disease-modifying therapies, distinct from supportive care interventions such as erythropoiesis-stimulating agents and does not extend to drug ...